Fucoidan from Saccharina japonica Alleviates Hyperuricemia-Induced Renal Fibrosis through Inhibiting the JAK2/STAT3 Signaling Pathway
Journal of Agricultural and Food Chemistry · 2023
DOI: 10.1021/acs.jafc.3c01349 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Agricultural and Food Chemistry, 2023. Verfasst von Lirui Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Food Hygiene, School of Public Health, Qingdao University, Qingdao, Shandong 266071, People's Republic of China. Hauptthemen laut MEDLINE: Hyperuricemia, Laminaria, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Shandong Postdoctoral Innovation Foundation.
Abstract (Originalsprache)
Fucoidan is a native sulfated polysaccharide mainly isolated from brown seaweed, with diverse pharmacological activities, such as anti-inflammatory and antifibrosis. Hyperuricemia (HUA) is a common metabolic disease worldwide and mainly causes hyperuricemic nephropathy, including chronic kidney disease and end-stage renal fibrosis. The present study investigated the protective function of fucoidan in renal fibrosis and its pharmacological mechanism. The renal fibrotic model was established with the administration of potassium oxonate for 10 weeks. The protein levels of related factors were assessed in HUA mice by an enzyme-linked immunosorbent assay (ELISA) and western blotting. The results showed that fucoidan significantly reduced the levels of serum uric acid, blood urea nitrogen (BUN), α-smooth muscle actin (α-SMA), and collagen I, and improved kidney pathological changes. Furthermore, renal fibrosis had been remarkably elevated through the inhibition of the epithelial-to-mesenchymal transition (EMT) progression after fucoidan intervention, suppressing the Janus kinase 2 (JAK2) signal transducer and activator of transcription protein 3 (STAT3) signaling pathway activation. Together, this study provides experimental evidence that fucoidan may protect against hyperuricemia-induced renal fibrosis via downregulation of the JAK2/STAT3 signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition and Food Hygiene, School of Public Health, Qingdao University, Qingdao, Shandong 266071, People's Republic of China.
- State Key Laboratory of Bioactive Seaweed Substances, Qingdao Mingyue Seaweed Group Company, Limited, Qingdao, Shandong 266499, People's Republic of China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Shandong Postdoctoral Innovation Foundation
Zitieren
APA
Sun, L., Liu, Q., Zhang, Y., Xue, M., Yan, H., Qiu, X., Tian, Y., Zhang, H., & Liang, H. (2023). Fucoidan from Saccharina japonica Alleviates Hyperuricemia-Induced Renal Fibrosis through Inhibiting the JAK2/STAT3 Signaling Pathway. Journal of Agricultural and Food Chemistry. https://doi.org/10.1021/acs.jafc.3c01349
Vancouver
Sun L, Liu Q, Zhang Y, Xue M, Yan H, Qiu X, et al. Fucoidan from Saccharina japonica Alleviates Hyperuricemia-Induced Renal Fibrosis through Inhibiting the JAK2/STAT3 Signaling Pathway. Journal of Agricultural and Food Chemistry. 2023. doi:10.1021/acs.jafc.3c01349
BibTeX
@article{Sun2023,
author = {Sun, Lirui and Liu, Qing and Zhang, Yabin and Xue, Meilan and Yan, Hongxue and Qiu, Xia and Tian, Yingjie and Zhang, Huaqi and Liang, Hui},
title = {Fucoidan from Saccharina japonica Alleviates Hyperuricemia-Induced Renal Fibrosis through Inhibiting the JAK2/STAT3 Signaling Pathway},
journal = {Journal of Agricultural and Food Chemistry},
year = {2023},
doi = {10.1021/acs.jafc.3c01349}
}
EUVIMED